Diflucan Linked to Birth Defects
In August 2011, the FDA issued an additional warning against the anti-fungal medication, Diflucan. Diflucan has been linked to causing birth defects in children if their mothers took Diflucan while pregnant. The FDA has also changed Diflucan from a Class C drug to a Class D drug, providing an additional warning against Diflucan for pregnant women. Currently, doctors are encouraged to warn women against the dangers of ingesting this drug if pregnant and the serious risks it poses to unborn children.
Diflucan is an anti-fungal drug produced by the pharmaceutical giant Pfizer. It is used to combat yeast infections, meningitis, and other fungal infections. But when taken during pregnancy, it can pose serious risk to unborn children. Women who have taken high doses of Diflucan during pregnancy, especially during the first trimester, have reported serious birth defects in their newborns. Such defects include congenital heart disease, cleft palate, cleft lip, abnormal face or skull formations, and various other abnormalities.
Numerous pharmaceutical drug attorneys are investigating the serious claims against Diflucan. If you or anyone you know has experienced similar problems while on Diflucan, contact the law offices of Arias, Ozzello & Gignac today for a free consultation.


